Fundraising FoxAdcendo
4 known investors
Find your way into Adcendo
Sign up to see every warm intro you have to Adcendo
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Adcendo team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Adcendo develops antibody-drug conjugates (ADCs) engineered to treat cancers with high unmet medical needs. The company translates scientific innovation into clinically differentiated medicines for patients with advanced solid tumors and other cancer types.
Investors · 4
How we know: the company's own site · a partner's Signal profile · Not right? Tell us
How we know: Ysios Capital's portfolio page · a partner's Signal profile · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: a partner's Signal profile · Not right? Tell us
How we know: press coverage · funding news · Not right? Tell us
Funding
SEC filings, press & company announcements$75M disclosed across 1 of 2 rounds · 2024–2026
- $75MSeries CApr 2026 · 3 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Adcendo do?
- Adcendo develops antibody-drug conjugates (ADCs) engineered to treat cancers with high unmet medical needs. The company translates scientific innovation into clinically differentiated medicines for patients with advanced solid tumors and other cancer types.
- Who are Adcendo's investors?
- Adcendo's investors include Vida Ventures, Ysios Capital, HealthCap, Jeito Capital.
- How much funding has Adcendo raised?
- Adcendo has disclosed $75M raised across 1 of its 2 known rounds.